IRIS
PILOTTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.326
EU - Europa 1.263
AS - Asia 474
AF - Africa 6
OC - Oceania 6
SA - Sud America 2
Totale 10.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.318
SE - Svezia 380
CN - Cina 353
IT - Italia 233
UA - Ucraina 148
DE - Germania 114
FI - Finlandia 99
GB - Regno Unito 91
FR - Francia 90
VN - Vietnam 55
IE - Irlanda 28
IN - India 26
BE - Belgio 21
NL - Olanda 14
RU - Federazione Russa 13
CA - Canada 7
ES - Italia 7
HK - Hong Kong 7
JP - Giappone 6
IR - Iran 5
SG - Singapore 5
AT - Austria 4
AU - Australia 3
BG - Bulgaria 3
IL - Israele 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PL - Polonia 3
RO - Romania 3
ZA - Sudafrica 3
CZ - Repubblica Ceca 2
HR - Croazia 2
ID - Indonesia 2
MA - Marocco 2
PH - Filippine 2
TH - Thailandia 2
BR - Brasile 1
CH - Svizzera 1
CR - Costa Rica 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
TW - Taiwan 1
Totale 10.077
Salva come PNG Salva come JPEG
Città #
Fairfield 1.371
Woodbridge 921
Ashburn 707
Houston 699
Chandler 658
Seattle 585
Cambridge 542
Wilmington 448
Ann Arbor 357
Jacksonville 345
Nyköping 341
Lawrence 151
Roxbury 151
Nanjing 114
Des Moines 104
Beijing 91
New York 82
San Diego 68
Dearborn 67
Dong Ket 53
Boardman 43
Princeton 43
Paris 41
Inglewood 40
Taranto 37
Bari 32
Brooklyn 30
Ostuni 28
Dublin 27
London 27
Redwood City 26
Shenyang 24
Nanchang 23
Washington 23
Ruvo Di Puglia 22
Brussels 21
Strasbourg 21
Pune 20
Jiaxing 17
Hebei 15
Changsha 13
Falls Church 12
Foggia 12
Helsinki 10
Los Angeles 10
San Mateo 10
Milan 9
Norwalk 9
Tianjin 9
Hefei 8
Henderson 8
Kilburn 7
Leawood 7
Edinburgh 6
Padova 6
Savona 6
Augusta 5
Chicago 5
Guangzhou 5
Madrid 5
Acton 4
Ardabil 4
Earth City 4
Hounslow 4
Jinan 4
Kunming 4
Messina 4
Miami 4
Ningbo 4
Redmond 4
Singapore 4
Vienna 4
Auckland 3
Hong Kong 3
Moscow 3
New Bedfont 3
Rome 3
San Francisco 3
Santa Clara 3
Sofia 3
Tonbridge 3
Toronto 3
Ahmedabad 2
Atlanta 2
Baotou 2
Bassano del Grappa 2
Bitetto 2
Bitonto 2
Bovisio-Masciago 2
Central 2
Changwat Sara Buri 2
Charlotte 2
Chiswick 2
Chongqing 2
Como 2
Denver 2
Genoa 2
Genova 2
Grafing 2
Indiana 2
Totale 8.691
Salva come PNG Salva come JPEG
Nome #
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 191
Development of a smart post-hospitalization facility for older people by using domotics, robotics, and automated tele-monitoring 164
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 133
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 127
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 123
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 116
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 114
Paraplegia due to Anterior Spinal Artery Stroke: Rehabilitative Program on Lower Extremity Weakness and Locomotor Function 114
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 110
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 109
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 106
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 105
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 105
Vascular risk factors, alcohol intake, and cognitive decline 104
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 104
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 103
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 102
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 100
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 98
Cognitive frailty: Predementia syndrome and vascular risk factors 97
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 97
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 96
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 95
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 95
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 94
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 93
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 92
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 92
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 90
Dietary unsaturated fatty acids and risk of mild cognitive impairment 89
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 88
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 86
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 84
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 83
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 83
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 83
Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis 83
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 82
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 82
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease 81
The Multidimensional Prognostic Index in general practice: One-year follow-up study 81
Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder 81
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 80
Mediterranean diet in predementia and dementia syndromes 80
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? 80
Lipoproteins, vascular-related genetic factors, and human longevity 79
Robotic balance assessment in community-dwelling older people with different grades of impairment of physical performance 79
Nutrition, frailty, and Alzheimer's disease. 77
Different models of frailty in predementia and dementia syndromes. 77
Robot-based assessment of sitting and standing balance: Preliminary results in Parkinson's disease 77
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients 76
Dietary patterns and protection against Alzheimer disease and cognitive decline 76
Apolipoprotein E, dementia, and human longevity 76
Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies 76
The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) 76
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 75
Current epidemiological approaches to the metabolic-cognitive syndrome. 75
Apolipoprotein E genotypes in mild cognitive impairment subtypes 75
Higher total cholesterol, cognitive decline, and dementia 74
Diet and Alzheimer's disease risk factors or prevention: the current evidence 74
The prognostic significance of geriatric syndromes and resources 74
Comprehensive Geriatric Assessment 73
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study 73
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 72
APOE and Alzheimer disease: a major gene with semi-dominant inheritance 72
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 72
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease 72
Comprehensive Geriatric Assessment in the Hospital 71
A New Computer-Based Tool to Reduce Potentially Inappropriate Prescriptions in Hospitalized Geriatric Patients 71
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 70
Enteral tube feeding and mortality in hospitalized older patients: A multicenter longitudinal study 70
Management of beta-thalassemia-associated osteoporosis 69
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 69
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease 69
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 68
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. 68
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 68
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease 68
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 67
Diet, cholesterol metabolism, and Alzheimer's disease: Apolipoprotein E as a possible link? 66
Reply to Letter to the Editor “Polypharmacy in elderly people with diabetes admitted to hospital” 65
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms 64
Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. 64
Comprehensive Geriatric Assessment in Patients with Organ Failure 64
Evaluation design of effichronic: The chronic disease self-management programme (CDSMP) intervention for citizens with a low socioeconomic position 63
Urological-Geriatric Integrated Diagnostic-Therapeutic Pathway for elderly patients with urologic diseases 63
The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia 62
Effects of oral amino acid supplementation on Multidimensional Prognostic Index in hospitalized older patients: a multicenter randomized, double-blind, placebo-controlled pilot study 62
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease 61
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia 61
Cerebral vasoreactivity and intima-media thickness in Down syndrome: A case-control study 61
Plasma lipid disturbances and cognitive decline 60
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease 60
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease. 60
Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study 60
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 59
The Multidimensional Prognostic Index Predicts in-hospital length of stay in older patients: A multicentre prospective study 59
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 59
CGA and Clinical Decision-Making: The Multidimensional Prognostic Index 58
Implementation of the SELFY-MPI in five European countries: a multicenter international feasibility study 58
Totale 8.262
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.251
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019591 0 0 0 0 0 0 0 0 0 0 313 278
2019/20203.216 334 127 105 228 368 301 376 405 466 172 224 110
2020/20212.127 129 243 152 194 178 166 266 174 109 273 102 141
2021/20221.026 46 65 7 29 60 107 50 46 78 78 164 296
2022/20231.805 246 172 126 157 170 232 33 246 287 22 76 38
2023/2024634 57 105 53 49 54 173 28 50 21 34 10 0
Totale 10.492